Cagrilintide is a novel long-acting acylated amylin analogue currently under investigation for its potential in weight management research. This compound acts as a nonselective agonist for amylin receptors (AMYR) and calcitonin G protein-coupled receptors (CTR), demonstrating significant effects on weight reduction and appetite control.
As a research chemical, Cagrilintide shows promise for scientific studies related to obesity and metabolic disorders. The compound is supplied as a white freeze-dried powder with purity exceeding 99%, ensuring reliable results for laboratory applications.
Our Cagrilintide is manufactured under strict GMP conditions, with each batch accompanied by comprehensive quality documentation. The product is carefully packaged to maintain stability and purity throughout storage and handling.
For research institutions and pharmaceutical developers, we offer flexible quantities from small research samples to bulk orders. The standard packaging includes 10 vials per box, each containing 10mg of high-purity Cagrilintide.
Note: This product is intended for research purposes only and not for human consumption. Proper handling procedures should be followed by qualified researchers in controlled laboratory settings.